Didier Saur

505 total citations
8 papers, 412 citations indexed

About

Didier Saur is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Didier Saur has authored 8 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Didier Saur's work include Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Didier Saur is often cited by papers focused on Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Didier Saur collaborates with scholars based in France, United States and United Kingdom. Didier Saur's co-authors include Steven G. Terra, Juan P. Frías, Brett Lauring, Amanda Darekar, Vaishali Sahasrabudhe, David L. Cutler, Susan Huyck, Dénes Páll, Harry Shi and Julio Rosenstock and has published in prestigious journals such as Diabetes Obesity and Metabolism, Clinical Therapeutics and The Journal of Clinical Pharmacology.

In The Last Decade

Didier Saur

8 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didier Saur France 8 364 250 137 56 50 8 412
Ros Swallow United Kingdom 5 500 1.4× 246 1.0× 369 2.7× 67 1.2× 71 1.4× 6 685
Thalia Marie Blicher Denmark 7 384 1.1× 286 1.1× 86 0.6× 15 0.3× 95 1.9× 10 498
Itamar Raz Israel 8 252 0.7× 110 0.4× 110 0.8× 43 0.8× 33 0.7× 16 359
Eva U. Graefe-Mody Germany 11 484 1.3× 153 0.6× 172 1.3× 260 4.6× 53 1.1× 12 547
R. Qiu United States 3 463 1.3× 171 0.7× 231 1.7× 23 0.4× 88 1.8× 5 483
Chiaki Kuriyama Japan 9 343 0.9× 178 0.7× 267 1.9× 37 0.7× 32 0.6× 13 464
Renee Kaste Germany 4 394 1.1× 229 0.9× 195 1.4× 32 0.6× 65 1.3× 5 411
Evangelia Tzeravini Greece 6 192 0.5× 94 0.4× 85 0.6× 15 0.3× 28 0.6× 14 299
Kevin K. Ng United States 4 171 0.5× 77 0.3× 95 0.7× 27 0.5× 107 2.1× 7 343
Shigeto Kanada Japan 9 188 0.5× 96 0.4× 114 0.8× 34 0.6× 14 0.3× 9 339

Countries citing papers authored by Didier Saur

Since Specialization
Citations

This map shows the geographic impact of Didier Saur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Saur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Saur more than expected).

Fields of papers citing papers by Didier Saur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Saur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Saur. The network helps show where Didier Saur may publish in the future.

Co-authorship network of co-authors of Didier Saur

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Saur. A scholar is included among the top collaborators of Didier Saur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Saur. Didier Saur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sahasrabudhe, Vaishali, Steven G. Terra, Anne Hickman, et al.. (2018). Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic Impairment. Clinical Therapeutics. 40(10). 1701–1710. 19 indexed citations
2.
Sahasrabudhe, Vaishali, Yali Liang, Kyle Matschke, et al.. (2018). Effect of Rifampin on the Pharmacokinetics of Ertugliflozin in Healthy Subjects. Clinical Therapeutics. 40(9). 1538–1547. 19 indexed citations
3.
Cutler, David L., Susan Zhou, Rajesh Krishna, et al.. (2018). Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects. Clinical Pharmacology in Drug Development. 8(3). 314–325. 22 indexed citations
4.
Raje, Sangeeta, Ernesto Callegari, Vaishali Sahasrabudhe, et al.. (2018). Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin. Clinical and Translational Science. 11(4). 405–411. 33 indexed citations
5.
Sahasrabudhe, Vaishali, Didier Saur, Kyle Matschke, et al.. (2018). A Phase 1, Randomized, Placebo‐ and Active‐Controlled Crossover Study to Determine the Effect of Single‐Dose Ertugliflozin on QTc Interval in Healthy Volunteers. Clinical Pharmacology in Drug Development. 7(5). 513–523. 15 indexed citations
6.
Sahasrabudhe, Vaishali, Steven G. Terra, Didier Saur, et al.. (2017). The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus. The Journal of Clinical Pharmacology. 57(11). 1432–1443. 42 indexed citations
7.
Terra, Steven G., Kristen Focht, Melanie J. Davies, et al.. (2017). Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone. Diabetes Obesity and Metabolism. 19(5). 721–728. 117 indexed citations
8.
Rosenstock, Julio, Juan P. Frías, Dénes Páll, et al.. (2017). Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy ( VERTIS MET ). Diabetes Obesity and Metabolism. 20(3). 520–529. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ros Swallow Breakdown of academic impact, for papers by Thalia Marie Blicher Breakdown of academic impact, for papers by Itamar Raz Breakdown of academic impact, for papers by Eva U. Graefe-Mody Breakdown of academic impact, for papers by R. Qiu Breakdown of academic impact, for papers by Chiaki Kuriyama Breakdown of academic impact, for papers by Renee Kaste Breakdown of academic impact, for papers by Evangelia Tzeravini Breakdown of academic impact, for papers by Kevin K. Ng Breakdown of academic impact, for papers by Shigeto Kanada
Rankless by CCL
2026